{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-027971","form_type":"8-K","ticker":"SGHT","cik":"0001531177","company_name":"Sight Sciences, Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.523620+00:00","generated_at":"2026-06-05T01:29:46.524568+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sight Sciences FY2023 revenue $81.1M (+14%); guides FY2024 $81-85M (0-5% growth)","bullets":["Q4 2023 revenue $18.8M (-9% YoY); net loss $10.7M ($0.22/sh) vs $16.9M loss ($0.35/sh) prior year.","FY2023 net loss $55.5M ($1.14/sh) vs $86.2M loss ($1.80/sh) in 2022; cash used reduced to $46.9M from $75.7M.","Operating expenses cut 20% in Q4; non-GAAP adjusted OpEx $22.3M vs $30.6M prior year.","New $65M senior secured credit facility with Hercules Capital; initial $35M drawn to refinance existing debt.","Full-year 2024 revenue guidance $81-85M (0-5% growth); expects double-digit growth in H2 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-027971","json":"https://secwatch.observer/filing/0000950170-24-027971.json","markdown":"https://secwatch.observer/filing/0000950170-24-027971.md","text":"https://secwatch.observer/filing/0000950170-24-027971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024027971/0000950170-24-027971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024027971/sght-20240307.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:29:46.524568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d8c7ce71196d50d427bcf3f29e9985c8a1190caa","claim":"Sight Sciences, Inc. reported the full year ended December 31, 2023 results: revenue $81.1 million. Guidance initiated.","evidence_excerpt":"Generated full year 2023 total revenue of $81.1 million, an increase of 14% compared to full year 2022 and generated fourth quarter 2023 total revenue of $18.8 million, a decrease of 9% compared to the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024027971/0000950170-24-027971-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year ended December 31, 2023"},{"label":"Revenue","value":"$81.1 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"f54185e8bdd033cb1608394110d429baf7a5e506","claim":"Sight Sciences, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $18.8 million. Guidance initiated.","evidence_excerpt":"Revenue for the fourth quarter of 2023 was $18.8 million, a decrease of $1.8 million, or 9%, compared to the same period in the prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024027971/0000950170-24-027971-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$18.8 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}